NCT01798199

Brief Summary

Virtual environments and information communication technologies (ICT) offer large perspectives in the field of assistive care and rehabilitation. As potentially endless, the scenarios and environment used using 3D can provide immersive social and interactive context for enjoyable and therapeutic exercises in the aging population. In addition it is also possible to use this type of serious game and scenario in very easy to use devices such as lap top or tablet. Social exclusion has many causes, Apathy as one of the most common behavioural disturbances found in old adults populations alters significantly social and emotional interaction. Even though, progress in VR has been made over the past year, the presence of such technology in daily living space is still at the embryonic stage. The European e-Inclusion policy stresses the importance of ICT in improving the quality of life in potentially disadvantaged groups, including older people and persons. The VERVE project is developing ICT tools to support the treatment of people who are at risk of social exclusion due to apathy associated with a disability. As people aged and autonomy worsen fear for safety and comfortable means to maintain social and Health Related Quality of Life (HRQL) status are public health issues. Moreover, even though older adults would like to perform some activities such as walking in the streets some are reluctant to go out of their homes as the external environment is perceived as potentially unsafe. Apathy, the most common behavioural symptoms in aging population is characterized by symptoms of reduced initiation and responsiveness to environmental interactions. The syndrome of Apathy takes form of diminished goal-directed behaviour, characterised by emotional blunting, loss of initiative and loss of interest. Apathy along with the nosological characteristics of dementia induces impairment in autonomy level and therefore dependence as cognitive impairments worsened. The importance of stimulation could be related to the concept of engagement defined as the act of being occupied or involved with an external stimulus. Engaging older person with or without Alzheimer's disease and related disorders in appropriate activities has been shown to yield beneficial HRQL effects such increasing positive emotion, improving cognition, functional autonomy and quality of life. Accordingly, enriched environments with high definition virtual representation of cities and activities of interest have the potentials not only to encourage patients to get active in a safe and interactive environment but also to create access to enjoyable and stimulating settings for the more severe patients. The VR setting from VERVE proposed personalised and populated environments available on two different, but interlinked hardware platforms: 1/: standard gaming set-up in the home, nursing home or day hospital therapy group; and 2/ mobile tracked internet devices (e.g.,IPad). The system will ensure maximum openness and dissemination by using 3D Web technologies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2013

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2012

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 25, 2013

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2013

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

September 1, 2015

Status Verified

August 1, 2015

Enrollment Period

1.3 years

First QC Date

November 21, 2012

Last Update Submit

August 31, 2015

Conditions

Keywords

Alzheimervirtual reality systemAlzheimer's disease related conditions

Outcome Measures

Primary Outcomes (1)

  • the participants and careers acceptability

    The primary objective is to evaluate the participants and careers acceptability in short and long term use of the VERVE light portable system used for cognitive stimulation of patients with cognitive pathologies.

    8 weeks

Secondary Outcomes (4)

  • To assess the impact of behavioral disturbances over the use of the VR using the NPI and the Apathy Inventory

    at 3, 4 and 8 weeks

  • To describe the parameters those facilitate engagement within the designs of VERVE VR setting using the engagement scale OME

    at 1, 2, 3, a weeks

  • To assess the potential acceptability and preventive effectiveness of such setting in home setting using visual analogic scale and EQ-D6

    at 3, 4, 8 weeks

  • To assess cognitive impact of the light VERVE setting. Using Stroop, TMT, VAT and functional task (IADL)

    First day and 4 weeks

Study Arms (1)

Alzheimer disease

EXPERIMENTAL
Other: The training by Verve System

Interventions

Alzheimer disease

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or Female aged ≥ 60 years.
  • Subject presenting a diagnosis of MCI according to the criteria of the National Institute on Aging and Alzheimer Association group (Albert M.S., 2011) ; or Alzheimer disease at the prodromal stage (Dubois B., 2010 )
  • Subject presenting a score of 0 at the " Tremor " and " Rigidity " items from the UPDRS III
  • Patient not presenting a major depression episode according to the DSM IV-R;
  • Be affiliate to the social security system (For French patients only);
  • Case of patients under guardianship after agreement of the guardian (legal entity);
  • Signed and dated a written informed consent obtained from the subject

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

CHU de Nice

Nice, 06000, France

Location

EHPAD Valrose

Nice, 06000, France

Location

EHPAD Villa Hélios Saint Jean

Nice, 06000, France

Location

MeSH Terms

Conditions

Alzheimer Disease

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Philippe ROBERT, PU-PH

    Centre Hospitalier Universitaire de Nice

    STUDY DIRECTOR
  • Renaud DAVID, PH

    CHU NICE

    STUDY CHAIR
  • Guillaume SACCO, PH

    Centre Hospitalier Universitaire de Nice

    STUDY CHAIR
  • Jean Michel TURPIN, PH

    Centre Hospitalier Universitaire de Nice

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 21, 2012

First Posted

February 25, 2013

Study Start

May 1, 2013

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

September 1, 2015

Record last verified: 2015-08

Locations